- Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab(2020)
Auteurs: Anne Rogiers, Christophe Leys, Justine Lauwyck, Adrian Schembri, Gil Awada, Julia Katharina Schwarze, Jennifer De Cremer, Peter Theuns, Paul Maruff, Mark De Ridder, et al.
- Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study(2020)
Auteurs: Anne Rogiers, Christophe Leys, Jennifer De Cremer, Gil Awada, Adrian Schembri, Peter Theuns, Mark de Ridder, Bart Neyns
Pagina's: 3267-3278
Aantal pagina's: 12
- Axitinib plus avelumab in the treatment of recurrent glioblastoma(2020)
Auteurs: Gil Awada, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, et al.
